IDF Europe Symposium at EASD: 'The use of Data in Diabetes - A Person-Centred Approach'
Last update: 27/09/2021
This year’s Symposium will take place on September 27 from 14.30 to 15.45 CET. at Berlin Hall.
Today, digitalisation is transforming diabetes care, probably more rapidly than any other therapeutic area. Ever-increasing amounts of health data are becoming available including data from electronic medical records, clinical trials, medical devices, apps, etc. The use of data is reshaping diabetes prevention and care. It is transforming the relationship between people living with diabetes (PwD) and healthcare professionals (HCPs). It has the potential to improve health outcomes, accelerate research and inform policy making. However, the use and sharing of data bring challenges and ethical questions, regarding, for example, data access, privacy and ownership.
A panel comprised of PwD, HCPs and representatives from academia, industry and health authorities will discuss the rationale and prerequisites for data sharing and use. They will explore how at times divergent interests can also converge to promote PwD engagement and drive holistic changes that benefit PwD and other stakeholders.
• Jose Manuel Boavida, IDF Europe Board Member, President of the Portuguese Diabetes Association (APDP) • Magda Chlebus, Executive Director for Science and Regulatory Affairs, EFPIA • Bastian Hauck, IDF Europe Board Members, CEO #dedoc, T1 diabetes advocate • Kari Kivinen, T2 diabetes advocate • Niek Klazinga, Head OECD health Quality Indicator Programme • Stan Shepherd, CEO, Instant Medical Access • Tanel Ross, Advisor, Supreme Council of Health, Kingdom of Bahrain • Hugo Van Haastert, Unit B.3, DG Sante